News
Systemic lupus erythematosus is associated with an increased risk for pulmonary manifestations, including ILD and pulmonary hypertension.
1d
Zacks Investment Research on MSNFate Therapeutics' Lupus Candidate FT819 Gets FDA RMAT TagFate Therapeutics FATE recently announced that the FDA has granted the Regenerative Medicine Advanced Therapy (RMAT) ...
China Bluetooth alternative Star Flash leads a shift to homegrown tech with support for IoT, smart homes, and connectivity.
Megyn Kelly, the American journalist, regrets her decision to get the Covid-19 vaccine, citing an autoimmune diagnosis ...
Just 5% of pediatric providers feel highly confident in evaluating and managing neuropsychiatric SLE in youth.
Despite its clinical relevance, the prevalence and contributing risk factors for recurrent pericarditis in individuals with ...
Gómez-Sifontes, A. , Diaz-Tablero, J. and Rodriguez, Y. (2025) Anti-C1q Antibodies as Markers of Renal Involvement in Patients with Systemic Lupus Erythematosus, Bolivar City, Venezuela. Open Access ...
Researchers have found in a new study that it is risky to use oral minoxidil for alopecia among patients with S.L.E..
Artiva Biotherapeutics, Inc. (Nasdaq: ARTV), a clinical-stage biotechnology company whose mission is to develop effective, safe, and accessible cell therapies ...
Dr. Banerjee received his medical degree from Christian Medical College in Vellore, India, and he completed his residency in ...
The FDA's fast track designations will facilitate rapid development and expedited review of ALLO's autoimmune disease candidate.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results